Literature DB >> 3756437

Occult hepatic metastases in colorectal carcinoma.

I G Finlay, C S McArdle.   

Abstract

Occult hepatic metastases (OHMs) were detected by ultrasound and/or CT scanning in 17 of 71 (24 per cent) patients undergoing apparently curative resection for colorectal carcinoma. One of the patients with OHMs survived 5 years; in contrast, only 5 of 54 patients without evidence of OHMs at surgery died of disseminated disease. The presence or absence of OHMs at the time of surgery predicts the majority of deaths from disseminated disease following apparently curative resection for colorectal carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3756437     DOI: 10.1002/bjs.1800730918

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  52 in total

1.  Clinical risk score can be used to select patients for staging laparoscopy and laparoscopic ultrasound for colorectal liver metastases.

Authors:  A J Shah; J Phull; M D Finch-Jones
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 2.  Natural history of liver metastases from colorectal carcinoma.

Authors:  J Norstein; W Silen
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

3.  Endoscopic transanal resection for rectal cancer.

Authors:  M G Kettlewell
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

4.  Clinical importance of DNA content in rectal cancer measured by flow cytometry.

Authors:  J R Jass; K Mukawa; H S Goh; S B Love; D Capellaro
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

5.  Follow-up recommendations for colon cancer.

Authors:  W Donald Buie; Jo-Anne P Attard
Journal:  Clin Colon Rectal Surg       Date:  2005-08

6.  Management of hepatic metastases from colorectal cancer.

Authors:  Ketan R Sheth; Bryan M Clary
Journal:  Clin Colon Rectal Surg       Date:  2005-08

7.  Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer.

Authors:  W F Miles; J D Greig; J Seth; C Sturgeon; S J Nixon
Journal:  Br J Gen Pract       Date:  1995-06       Impact factor: 5.386

8.  Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.

Authors:  Angelita Habr-Gama; Rodrigo Oliva Perez; Wladimir Nadalin; Jorge Sabbaga; Ulysses Ribeiro; Afonso Henrique Silva e Sousa; Fábio Guilherme Campos; Desidério Roberto Kiss; Joaquim Gama-Rodrigues
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

Review 9.  Resection of hepatic metastases from colorectal cancer. Biologic perspective.

Authors:  G Steele; T S Ravikumar
Journal:  Ann Surg       Date:  1989-08       Impact factor: 12.969

10.  Outcome in colorectal adenocarcinoma: two seven-year studies of a population.

Authors:  N L Gordon; A A Dawson; B Bennett; G Innes; O Eremin; P F Jones
Journal:  BMJ       Date:  1993-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.